Anti–BAFF-R antibody VAY-736 demonstrates promising preclinical activity in CLL and enhances effectiveness of ibrutinib

Autor: McWilliams, Emily M. *, Lucas, Christopher R. *, Chen, Timothy *, Harrington, Bonnie K., Wasmuth, Ronni, Campbell, Amanda, Rogers, Kerry A., Cheney, Carolyn M., Mo, Xiaokui, Andritsos, Leslie A., Awan, Farrukh T., Woyach, Jennifer, Carson, William E., III, Butchar, Jonathan, Tridandapani, Susheela, Hertlein, Erin, Castro, Carlos E., Muthusamy, Natarajan *, Byrd, John C. **
Zdroj: In Blood Advances 12 February 2019 3(3):447-460
Databáze: ScienceDirect